Neuroscience Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Neuroscience stocks.

Neuroscience Stocks Recent News

Date Stock Title
Nov 1 NXL Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on November 5th
Nov 1 NXL Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements
Nov 1 NXL LOBO EV and Nexalin Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Nov 1 ITCI Intra-Cellular Therapies Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Nov 1 PRAX Praxis Precision Medicines to Announce Third Quarter 2024 Financial Results and Host Conference Call on Wednesday, November 6, 2024
Oct 31 AVXL Anavex gains as lead asset slows Alzheimer’s disease progression by a third
Oct 31 AVXL Anavex’s Blarcamesine Achieves Pre-specified Efficacy in Phase IIb/III Alzheimer’s Trial: Data Presented at CTAD Conference 2024
Oct 31 ITCI Intra-Cellular Therapies Inc (ITCI) Q3 2024 Earnings Call Highlights: Robust Sales Growth and ...
Oct 30 ITCI Intra-Cellular Therapies, Inc. (ITCI) Q3 2024 Earnings Call Transcript
Oct 30 ITCI Intra-Cellular jumps on Q3 beat as Caplyta outlook brightens
Oct 30 ITCI ITCI Q3 Loss Wider Than Expected, Revenues Top on Higher Caplyta Sales
Oct 30 ITCI Intra-Cellular Therapies (ITCI) Reports Q3 Loss, Tops Revenue Estimates
Oct 30 ITCI Intra-Cellular: Q3 Earnings Snapshot
Oct 30 ITCI Intra-Cellular Therapies GAAP EPS of -$0.25 misses by $0.04, revenue of $175.4M beats by $3.05M
Oct 30 ITCI Intra-Cellular Therapies Reports Third Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 Caplyta Sales Guidance
Oct 29 ITCI Intra-Cellular Therapies Q3 2024 Earnings Preview
Oct 28 NRSN NeuroSense Secures Key FDA Meeting to Advance its Phase 3 ALS Trial and NDA Submission
Oct 28 NXL Nexalin Technology Announces Landmark Study on Alzheimer's Disease and Deep Intracranial Frequency Stimulation Published in Journal of Alzheimer's Disease
Oct 28 NXL EXCLUSIVE: Nexalin Technology Says New Data Confirms Implantable Device Improves Cognitive Function, Restores Brain Activity in Alzheimer's Patients
Oct 28 NRSN EXCLUSIVE: Nano-Cap NeuroSense Schedules FDA Meeting To Advance Lead Program And Marketing Application Submission
Neuroscience

Neuroscience (or neurobiology) is the scientific study of the nervous system. It is a multidisciplinary branch of biology that combines physiology, anatomy, molecular biology, developmental biology, cytology, mathematical modeling and psychology to understand the fundamental and emergent properties of neurons and neural circuits. The understanding of the biological basis of learning, memory, behavior, perception, and consciousness has been described by Eric Kandel as the "ultimate challenge" of the biological sciences.The scope of neuroscience has broadened over time to include different approaches used to study the nervous system at different scales and the techniques used by neuroscientists have expanded enormously, from molecular and cellular studies of individual neurons to imaging of sensory and motor tasks in the brain. Neuroscience has also given rise to such other disciplines as neuroeducation, neurolinguistics, neuroethics, and neurolaw.
As a result of the increasing number of scientists who study the nervous system, several prominent neuroscience organizations have been formed to provide a forum to all neuroscientists and educators. For example, the International Brain Research Organization was founded in 1960, the International Society for Neurochemistry in 1963, the European Brain and Behaviour Society in 1968, and the Society for Neuroscience in 1969.

Browse All Tags